149 related articles for article (PubMed ID: 7019720)
1. Measurement of circulating prostacyclin.
Haslam RJ; McClenaghan MD
Nature; 1981 Jul; 292(5821):364-6. PubMed ID: 7019720
[No Abstract] [Full Text] [Related]
2. Is prostacyclin a physiologically important circulating anti-platelet agent?
Steer ML; MacIntyre DE; Levine L; Salzman EW
Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
[No Abstract] [Full Text] [Related]
3. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
Lagarde M; Ghazi I; Dechavanne M
Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
Oyekan AO; Botting JH
Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
[TBL] [Abstract][Full Text] [Related]
5. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
[No Abstract] [Full Text] [Related]
6. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
7. Vitamin E deficiency: its effect on platelet-vascular interaction in various pathologic states.
Stuart MJ
Ann N Y Acad Sci; 1982; 393():277-88. PubMed ID: 6756257
[No Abstract] [Full Text] [Related]
8. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
[TBL] [Abstract][Full Text] [Related]
9. Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions.
Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M; Kawasaki A; Okegawa T; Tsuboshima M
Thromb Res; 1980 Dec 1-15; 20(5-6):573-80. PubMed ID: 7233385
[No Abstract] [Full Text] [Related]
10. Release of a prostacyclin-like substance into the circulation of dogs by intravenous adenosine 5'-diphosphate.
Hemker DP; Shebuski RJ; Aiken JW
J Pharmacol Exp Ther; 1980 Feb; 212(2):246-52. PubMed ID: 6985960
[No Abstract] [Full Text] [Related]
11. Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?
Mikhailidis DP; Mikhailidis AM; Woollard ML; Dandona P
Clin Sci (Lond); 1982 Feb; 62(2):177-81. PubMed ID: 7032807
[TBL] [Abstract][Full Text] [Related]
12. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Bussolino F; Camussi G
Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
[TBL] [Abstract][Full Text] [Related]
13. Heparin opposes prostanoid and non-prostanoid platelet inhibitors by direct enhancement of aggregation.
MacIntyre DE; Handin RI; Rosenberg R; Salzman EW
Thromb Res; 1981 Apr 1-15; 22(1-2):167-75. PubMed ID: 6270842
[No Abstract] [Full Text] [Related]
14. Stability of prostaglandin I2 in human blood.
Pifer DD; Cagen LM; Chesney CM
Prostaglandins; 1981 Feb; 21(2):165-75. PubMed ID: 7012932
[TBL] [Abstract][Full Text] [Related]
15. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
Sokolov EI; Lavrenova NIu; Goloborodova IV
Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
[TBL] [Abstract][Full Text] [Related]
16. Platelet alterations in shear flow: dose response of prostacyclin on human platelets.
Hung TC; Butter DB; Graham MF; Lewis JH; Zhao JQ; Haubold AD
Trans Am Soc Artif Intern Organs; 1983; 29():436-41. PubMed ID: 6424310
[No Abstract] [Full Text] [Related]
17. The antiaggregatory effectiveness of PGI2 and its binding to specific platelet receptors. A comparative study.
Jaschonek K; Renn W; Weisenberger H
Prog Clin Biol Res; 1987; 242():13-8. PubMed ID: 3313410
[No Abstract] [Full Text] [Related]
18. Transitory failure of ADP to induce platelet aggregation in plasma from a young healthy woman.
Wennmalm A
Prostaglandins Med; 1980 May; 4(5):325-8. PubMed ID: 6996016
[TBL] [Abstract][Full Text] [Related]
19. Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbit.
Elam MB; Lipscomb GE; Chesney CM; Terragno DA; Terragno NA
Prostaglandins; 1980 Dec; 20(6):1039-51. PubMed ID: 7010445
[TBL] [Abstract][Full Text] [Related]
20. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
